Focal photocoagulation less invasive for microaneurysms

Article

Focal photocoagulation may be a less invasive method for the treatment of microaneurysms, according to a paper published in the journal Retina.

Focal photocoagulation may be a less invasive method for the treatment of microaneurysms, according to a paper published in the journal Retina.

A team led by Dr Y. Yamada, Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, analysed 13 eyes of diabetic patients who underwent focal photocoagulation for clinically significant macula oedema.

The microaneurysms were evaluated preoperatively, immediately postoperatively and one and two months after photocoagulation with SD-OCT. Fluorescein angiography and colour fundus photography were also used to evaluate the microaneurysms.

Preoperatively, the microaneurysms were circular or elliptical in structure with hyperreflective foci within vessel walls. Immediately after the procedure there were indistinct lesions with hyperreflectivity around the microaneurysms.

Efficient photocoagulations procedures resulted in retinal changes limited to within the inner retina around the microaneurysms and there were no changes in the retinal pigment epithelium. Within two postoperative months the microaneurysms transformed into fine scars and the retinal structure was normalized.

The average retinal foveal thickness increased from 432 ± 70 μm preoperatively to 373 ± 84 μm at the two-month follow-up. SD-OCT is useful for assessing the efficacy of photocoagulations procedures.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.